The combination of ulinastatin and somatostatin reduces complication rates in acute pancreatitis: a systematic review and meta-analysis of randomized controlled trials

The combination of ulinastatin and somatostatin reduces complication rates in acute pancreatitis: a systematic review and meta-analysis of randomized controlled trials

Abstract Currently, there is no specific pharmaceutical agent for treating acute pancreatitis (AP). Somatostatin and its analogues have been used to prevent the autolysis of the pancreas in AP, however, their effectiveness has not been confirmed. This investigation aimed to examine the efficacy of u...

Full description

Bibliographic Details
Main Authors: István László Horváth, Stefania Bunduc, Péter Fehérvári, Szilárd Váncsa, Rita Nagy, Gantsetseg Garmaa, Dénes Kleiner, Péter Hegyi, Bálint Erőss, Dezső Csupor
Format: Article
Language:English
Published: Nature Portfolio 2022-10-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-22341-7

Similar Items

Similar Items